XML 55 R28.htm IDEA: XBRL DOCUMENT
v3.25.2

Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Accounting Policies [Abstract] |
Schedule of Other Nonoperating Income (Expense) | Other (Expense) Income, Net The following table summarizes the components of other (expense) income, net.
|  |  | Year Ended June 30,
|  |  |  |  | 2025 |  | 2024 |  | 2023
(Losses) gains on derivatives not designated as hedging instruments (1) |  |  |  |  | $ | (35,027) |  |  | $ | 3,915 |  |  | $ | 3,311 |
Currency-related gains (losses), net (2) |  |  |  |  | 21,090 |  |  | (2,818) |  |  | 16,350 |
Other gains (losses) |  |  |  |  | 355 |  |  | 486 |  |  | (1,163) |
Total other (expense) income, net |  |  |  |  | $ | (13,582) |  |  | $ | 1,583 |  |  | $ | 18,498 |
_____________________ (1) Includes realized and unrealized gains and losses on derivative currency forward and option contracts not designated as hedging instruments, as well as the ineffective portion of certain interest rate swap contracts that have been de-designated from hedge accounting. For contracts not designated as hedging instruments, we realized gains (losses) of $2,706, $(1,078) and $39,133, respectively, for the fiscal years ended June 30, 2025, 2024 and 2023. Refer to Note 4 for additional details relating to our derivative contracts. (2) Currency-related gains (losses), net primarily relates to significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. In addition, during all fiscal years presented, we had certain cross-currency swaps designated as cash flow hedges, which hedge the remeasurement of certain intercompany loans; refer to Note 4 for additional details relating to these cash flow hedges.
Schedule of Weighted Average Number of Shares | The following table sets forth the reconciliation of the weighted-average number of ordinary shares.
|  |  | Year Ended June 30,
|  |  |  |  | 2025 |  | 2024 |  | 2023
Weighted average shares outstanding, basic |  |  |  |  | 24,923,797 |  |  | 26,151,968 |  |  | 26,252,860 |
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/PSUs/warrants (1) |  |  |  |  | 713,068 |  |  | 852,719 |  |  | — |
Shares used in computing diluted net income (loss) per share attributable to Cimpress plc |  |  |  |  | 25,636,865 |  |  | 27,004,687 |  |  | 26,252,860 |
Weighted average anti-dilutive shares excluded from diluted net income (loss) per share attributable to Cimpress plc (1)(2) |  |  |  |  | 1,001,612 |  |  | 96,207 |  |  | 2,834,351 |
___________________ (1) In the periods in which a net loss is recognized, the impact of share options, PSUs, RSUs and warrants is excluded from shares used in computed diluted net income (loss) per share as it is anti-dilutive. Any equity awards that have a performance condition are not included in dilutive or anti-dilutive shares until the performance condition would have been met as of the end of the reporting period. (2) On May 1, 2020, we entered into a financing arrangement, which included 7-year warrants to purchase 1,055,377 of our ordinary shares with a strike price of $60 that have a potentially dilutive impact on our weighted average shares outstanding. For the years ended June 30, 2025 and 2024, the average market price of our ordinary shares was higher than the strike price of the warrants; therefore, the weighted average dilutive effect of the warrants were 147,329 and 220,668, respectively. For the year ended June 30, 2023, the average share price was below the strike price for the full fiscal year; therefore, the total 1,055,377 outstanding warrants were considered anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration